| Trial registration number
|
NCT04891250 |
Full text link
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04891250
|
First author
Last imported at : Feb. 4, 2022, 1:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Contact
Last imported at : Feb. 4, 2022, 1:30 p.m.
Source : ClinicalTrials.gov
|
Wilbroad Mutala; wmutale@yahoo.com
|
Registration date
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2021-05-18
|
Recruitment status
Last imported at : Feb. 4, 2022, 1:30 p.m.
Source : ClinicalTrials.gov
|
Withdrawn
|
Study design
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- individuals diagnosed positive for sars-cov-2 by real-time reverse transcription pcr
(rrt-pcr with presence of a fever, cough, and/or sore throat.
|
Exclusion criteria
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
- patients will be excluded if they report to be allergic to ivermectin or if there is
potential for a drug-drug interaction with ivermectin;
- have chronic illnesses (e.g., ischemic heart disease, heart failure, documented
cardiomyopathy, chronic kidney disease, chronic liver disease);
- have received ivermectin in the last 7 days; are pregnant or lactating;
- or have participated in any other clinical trial within the last month.
|
Number of arms
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Centre for Infectious Disease Research in Zambia
|
Inclusion age min
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
65
|
Countries
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Zambia
|
Type of patients
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Mild disease at enrollment
|
Severity scale
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
1: Mild disease at enrollment
|
Total sample size
Last imported at : Feb. 4, 2022, 1:30 p.m.
Source : ClinicalTrials.gov
|
0
|
primary outcome
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
All-cause COVID-19 related mortality;COVID-19 Infection
|
Notes
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Phase 4
|
Arms
Last imported at : May 19, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 693, "treatment_name": "Ivermectin", "treatment_type": "Antiparasitics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|